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Abstract. We describe our observations concerning
differences in two groups of young hypertensive
patients according to their renin activities after ACE
inhibition. Seventeen of these patients (age 26 ± 7
years), so far untreated, were investigated prospect-
ively for hormone levels (renin, aldosterone, vasopres-
sin), microalbuminuria, renal haemodynamics (inulin
and PAH clearance) and signs of organ damage
(echocardiography, fundoscopy). Secondary forms of
hypertension were excluded by routine methods,
including angiography. We differentiated two groups
of young hypertensive patients. Group 1 (n = 9) had
a false positive captopril test with elevated renin
activities after ACE inhibition with captopril (8.4±5
ng/ml per hour) compared to group 2 (renin activity:
2.2 ± 1.3 ng/ml per hour) or an increase of >400%
of renin activity after ACE inhibition. Baseline renin
activities and sodium excretion did not differ between
the groups. Group 1 also showed significantly greater
GFR, FF, and microalbuminuria, as well as signs of
organ damage, with left ventricular hypertrophy and
hypertensive changes in fundoscopy. There were no
differences between the groups concerning mean
arterial blood pressure and duration of hypertension.
In conclusion, we were able to demonstrate that
patients with highly stimulated renin activities showed
signs of visceral organ damage and renal hyper-
filtration compared to the normal renin activity group
after ACE inhibition. Investigations of the renin-
angiotensin-aldosterone system with ACE inhibitors
Correspondence and offprint requests to Christiane M Erley. MD.
University of Tuebingen, Medical Section III. Otfned-Muller-Str
10. 7400 Tuebingen. Gcrman>.
might constitute a helpful indicator of renal changes
and organ damages in young hypertensive patients.
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Introduction
Recently we reported the failure of the captopril test
to detect renal artery stenosis in young hypertensive
patients [1]. Nearly 40% of our young hypertensive
outpatients showed a marked increase of plasma
renin activities after ACE inhibition without showing
evidence of renal artery stenoses, as excluded by
angiography. Baseline renin activities did not differ
between the groups and pronounced responses to
captopril stimulation could not be explained by
different sodium excretion rates. This cohort of young
hypertensive patients with a false positive captopril
test showed microproteinuria significantly more often
compared to a control group.
As it is of great potential importance to evaluate
the association of renin concentrations, renal haemo-
dynamics, microalbuminuria, and vascular damage
in patients with essential hypertension we started a
prospective study in young hypertensive patients.
This article will report on our observations in 17
young hypertensive patients matched for blood pres-
sure as well as age and separated according to their
response to ACE inhibition.
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Subjects and methods
From April 1990 to November 1990 we prospectively
investigated 17 young outpatients with hypertension
according to their response to ACE inhibition and to signs
of organ damage including microalbuminuria. Twelve men
and five women with essential arterial hypertension were
selected for the study (mean age 27±6 years). They persist-
ently had an outpatient systolic blood pressure greater than
160mmHg and a diastolic blood pressure greater than
100 mmHg on an unrestricted diet and without drug ther-
apy, as measured on three different days after 5 min in the
supine position. Secondary forms of hypertension were
excluded by physical examination and routine laboratory
investigations. Examinations concerning renal haemo-
dynamics and organ damage were done in a blind manner
by independent physicians without knowing renin values.
Left ventricular wall thickness was measured by echocardi-
ography (two-dimensional echocardiography combined
with M-mode). Hormone concentrations were determined
at the end of the study period. In patients with high
concentrations of renin activity a transarterial angiography
was performed to exclude renal artery stenosis.
At the end of the investigation patients were assigned to
two groups according to their renin concentrations after
ACE inhibition. Group 1 was defined as having a false
positive captopril test, according to the criteria of Muller
ei al. [2]. Most of these patients had elevated stimulated
renin activities ( > 4 ng/ml per hour) or showed an increase
>400% of renin activities after ACE inhibition.
Patient characteristics are described in Table 1. There
was no difference concerning protein or sodium intake. All
patients were allowed to stay on their normal diet.
Blood pressure and microalbuminuria were measured on
at least three consecutive days. A so-called white coat
hypertension was ruled out by 24 h blood-pressure measure-
ments (Spacelabs 90202, Spacelabs Inc., Redmond Wash).
Blood pressure values given in Table 1 were also obtained
by these measurements and are given as mean values. This
device uses a standard upper arm cuff which is inflated at
regular preset intervals (every 20 min). Systolic, diastolic,
and mean arterial blood pressures were calculated and
interpreted by the help of an algorithm as the arterial
pressure fluctuations are transmitted to the cuff and tubing
system oscillometrically.
Concentrations of renin. aldosterone. and antidiuretic
hormone were assessed. According to Muller ei al. [2] blood
for determining plasm? renin activity was drawn only when
a normal sodium excretion rate was guaranteed (urinary
sodium was >80m\aI 1 in all patients). For routine blood
investigations and evaluation of hormone concentrations
blood was obtained after lying supine for 30 min. Then
25 mg captopril were administered orally. Sixty minutes
later venous blood samples were drawn for measurement
of stimulated plasma renin activities. Arterial blood pres-
sure was measured at the beginning and every 15 min.
Sodium, potassium, chloride, creatinine, urea nitrogen,
and glucose concentrations in serum samples were measured
with an automated system of chemical analysis (Hitachi,
Boehringer). The peripheral venous haematocrit was deter-
mined by microhaematocrit technique. Urinary albumin
was measured by enzyme-linked immunosorbent assay [3].
Urine samples were collected in 2-1 casein-coated polyethyl-
ene containers. Plasma renin activity, vasopressin, and
aldosterone values were determined with commercially
available radioimmunoassays.
Glomerular filtration rate (GFR) and renal blood flow
were assessed by means of a constant infusion technique
of inulin (Inutest; Laevosan; 20 ml contains 5.0 g polyfruc-
tosan) and PAH (p-aminohippurate; Nephrotest; BAG;
10 ml contain 2.2 g sodium aminohippurate) after an initial
loading dose starting at 8.30 a.m. (loading dose for inulin:
36 ml/m2 body surface area; loading dose for PAH: 6 ml/m2
body surface area) [4]. The C^ and CPAH were calculated
as urine concentration divided by plasma concentration,
multiplied by urine volume in millilitres per minute, and
corrected for body surface area (1.73 m2). Since there were
no significant differences in urine flow rates or clearances
from one collection period to another, all results were
expressed as single mean values of the triplicate determina-
tions for each patient. The filtration fraction was calculated
as CIM/CPAH and was expressed as a percentage of CPAH.
Student's Mest was used to determine statistical signific-
ance (P<0.05). Linear regressions and correlation coeffi-
cients were calculated to relate albuminuria and plasma
renin activities after ACE inhibition.
Table 1. Patient characteristics
Characteristics
Age (years)
Body mass index (kg m2)
Basal systolic BP (mmHg)
Basal diastolic BP (mmHg)
Mean arterial pressure (mmHg)
Basal pulse (beats min)
Duration of hy pertension (months)
CreaUnine (mg dl)
Sodium excretion (mval 1)
Positive family history for
hypertension (total numbers)
Subjects (n)
Group 1*
25.7 + 7.3
22.6+1.9
172±12
99 + 8
123 + 7
75+10
23 ±24
0.9 + 0.1
114+16
7
9
Group 2*
28 + 3.9
26.2±4.8
168 + 21
100 + 7
122±I0
76+15
31 + 14
0.9 + 0.1
96+.I9
3
S
*Mean values+.SD.
Group 1, patients with elevated plasma rzr.ir. aclivitv after ACE
inhibition; see Table 2.
Group 2, patients with normal plasma renin activity after ACE
inhibition, see Table 2.
BP, blood pressure.
Results
Both study groups were comparable with regard to
age and arterial blood pressure measured by 24 h
blood pressure measurement. There were no statistic-
ally significant differences regarding history of hyper-
tension and body mass index, nor in serum
concentrations of electrolytes, glucose, blood urea
nitrogen, venous haematocrit, and creatinine. The
difference in sodium excretion (114+; 16 mval 1 versus
96 2:19 mval 1) was not statistically significant.
There were significant (P<0.G\) differences in
plasma renin activities after ACE inhibition (group 1,
8.4+:5.3 ng ml per hour; group 2, 2.2± 1.3 ng ml per
hour; see also Table 2). Baseline plasma renin activit-
ies were slightly but not significantly increased in
group 1 (group 1, 2.0 ±1.1; group 2, 1.5^0.3). The
increase in renin activity after ACE inhibition
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Table 2. Patient renin, aldosterone and vasopressin profile
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TaWe4. Organ involvement and microalbuminuna
Profile
Baseline renin activities
(supine position) (ng/ml per hour)
Renin activities after
oral administration of
25 mg captopril (ng/ml per hour)
Increase of renin activities
after ACE inhibition (%)
Aldosterone (pg/ml)
Vasopressin (pg/ml)
Group 1
2.0±l.l
8 4±5.3
610±175
116±37
6±4
Group 2
1.5±0.3
2.2 ±1.3*
190±44"
I16±41
3±2*
Abnormal fundoscopy (n)
hypertensive fundus
grade 1 (n)
hypertensive fundus
grade 2 (n)
Diameter of
end-diastolic septum (mm)
Diameter of posterior
wall, end-diastolic (mm)
Microalbuminuria (mg/24 h)
Group 1
7
5
2
11.1±1.4
11.7±1.3
102 ±57
Group 2
4
4
0
9.5±0.9*
9.4±0 7*
17±7«
•Statistically significant.
**Mean values ±SD of the respective individual increase 'Statistically significant.
expressed as mean values of the individual increase
was more pronounced in group 1 (610± 175%) than
in group 2 (190 ±44%). Unlike plasma renin activity,
there were essentially no notable differences in plasma
aldosterone between the groups. Vasopressin concen-
trations were higher in group 1, with elevated renin
activities after ACE inhibition. This difference was
not statistically significant.
As regards renal function, the differences of inulin
clearance (119 ± 13 ml/min per 1.73 m2 in group 1
versus 105 + 5 ml/min per 1.73 m2 in group 2) and
filtration fraction (28 ± 3 % in group 1 versus 22 ± 3 %
in group 2) were significant. PAH clearance and
effective renal plasma flow (ERPF) were slightly but
not significantly elevated in group 2 (Table 3).
Investigations concerning organ involvement
(Table 4) showed that in group I seven of nine
patients showed hypertensive fundoscopic changes
(n = 5 for grade 1, n = 2 for grade 2). In contrast, in
group 2 only four of eight patients showed fundos-
copic changes which were less severe than in group 1
(no grade 2). Echocardiographic diameters of the
interventricular septum and posterior wall were
elevated in group 1 and normal in group 2. Micro-
albuminuria was significantly higher in group 1
(102 ± 57 mg/24 h versus 17 ± 7 mg/24 h).
Patients with elevated plasma renin activities after
ACE inhibition (group 1) had a positive correlation
of albuminuria and stimulated plasma renin activities
(Figure I).
Table 3. Renal function and haemodynamics
Parameters Group 1 Group 2
119±13 IO5±5°
482 ±57
Inulin clearance ( p . )
(ml/min per 1.73 mJ)
p-aminohippurate
clearance (CPAH) (ml min per 1.73 m2) 430±83
Filtration fraction
(CINCPAHxl00%) 28±3 22±3
'Statistically significant.
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Fig. I. Correlation of stimulated renin activities (renin after ACE
inhibition) and microalbuminuria in young hypertensive patients.
Group 1, patients with elevated plasma renin activity after ACE
inhibition (25 mg captopril, see Table 2); Group 2, patients with
normal plasma renin activity after ACE inhibition (25 mg captopril,
see Table 2).
r - correlation coefficient.
Discussion
In a population of young hypertensive patients up to
40% showed an elevation of plasma renin activities
after ACE inhibition [1]. We performed this prospect-
ive investigation in order to clarify whether there are
differences between young hypertensive patients with
elevated and normal renin activity responses after
ACE inhibition. We chose 17 patients without previ-
ous medication, matched for blood pressure, duration
of hypertension, and age, and divided them into two
ACE inhibition, renin activity and organ damage in young hypertensive patients 219
groups according to their renin response to ACE
inhibition.
In contrast to other investigations about differences
in the renin system of hypertensives [5-9], baseline
renin activities of our groups were nearly equal, with
a slight but not significant advantage of group 2. The
strong response to ACE inhibition in group 1 could
not be explained by differences of sodium excretion,
age, or aldosterone concentrations (Tables 1,2). Des-
pite nearly identical baseline renin activities, the
responses to ACE inhibition in group 1 are compar-
able to those in high-renin hypertensive patients
described by previous investigators [6,10-13]. The
slightly elevated aldosterone in group 1 seems to be
related to the overall increased renin concentration.
Vasopressin was higher in group 1 than in group 2
despite comparable blood pressures. The same obser-
vation was made in patients with high-renin hyperten-
sion and was thought to be related to hypovolaemia
[14]. Due to normal baseline renin activities these
patients could not be clearly classified as a group of
high-renin hypertensives, although we cannot exclude
that we may have studied patients in an early stage
of this disease.
There have been several observations on the rela-
tion of renin concentrations, renal haemodynamics,
microalbuminuria, organ damage, and risk of stroke
and heart attack [7,11,13,14]. In this context our
investigation concerning renal haemodynamics and
organ damage in young patients is of interest.
The assessment of renal haemodynamics (Table 3)
showed a slight but significantly higher inulin clear-
ance in group 1. Renal blood flow was slightly dimin-
ished compared to group 2. Group 1 showed a
significantly higher filtration fraction (Table 3).
The observed renal haemodynamic changes in our
patients could be interpreted as a more pronounced
vasoconstriction of efferent arterioles in patients of
group 1 (increased renin activities). Probably patients
suffering from this form of hypertension will develop
nephron damage at a later state of their disease. This
might occur as sequel of the high glomerular pressure
in the early state of the disease, according to observa-
tions in the rat model [15-17]. Our observations on
renal haemodynamics are in accordance with those
previously published for patients with microalbumin-
uria [18]. Other results concerning renal haemody-
namic changes in patients with essential hypertension
as to their renin status are conflicting [5,7,9,19]. Some
investigators described a reduced glomerular filtration
rate, others reported a normal or slightly elevated
glomerular filtration rate. Most of these differences
may be explained by heterogeneities of age, medica-
tion, and duration of hypertension. As our study
groups were matched, we attach importance to the
observations made, especially with reference to the
differences in renal haemodynamics and renin activit-
ies in young hypertensive patients.
Microalbuminuria was evident in group 1 and there
was a correlation between renin values after ACE
inhibition and microalbuminuria, especially in
patients with a markedly increased renin activity after
ACE inhibition (Figure 1). We consider microalbumi-
nuria to reflect the exposition of nephrons to renin
and angiotensin II. A correlation between albumin-
uria and filtration fraction or glomerular filtration
rate as reported by other investigators [18] could not
be reproduced in our study.
In accordance with observations that microalbumi-
nuria is related to other organ damage [20-22], we
were able to demonstrate that group 1 patients more
frequently showed signs of left ventricular hyper-
trophy and of vascular damage during fundoscopy.
Although microalbuminuria seems to reflect the situ-
ation at the renal microvascular site only, our findings
of a correlation between microalbuminuria and serum
renin concentrations may be the link between microal-
buminuria and overall vascular organ damage. This
suggests a direct renin-dependent vascular damage of
the whole vascular system. This would be supported
by data that in larger populations patients with high-
renin hypertension showed stroke and myocardial
infarction more often [23].
In conclusion, patients with increased renin concen-
trations after ACE inhibition more frequently showed
signs of organ damage and a more pronounced
microalbuminuria. Renal haemodynamics of these
patients showed increased glomerular filtration and
filtration fraction. This could be interpreted as an
adaptation of nephrons exposed to increased concen-
trations of renin and angiotensin II. Thus far it
remains unclear whether increased concentrations of
renin are the key to the disease or just a response to
other damage. Further follow-up investigations about
the vascular system, kidney morphology and clinical
outcome of these patients may answer this question
and will also indicate whether our patients belong to
a special form of hypertension or represent an early
state of so-called high-renin hypertension.
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